1
|
Upregulation of host genes during disease progression in bovine leukemia virus infection is independent of overexpression of viral transcriptional regulators in vitro. Arch Virol 2023; 168:98. [PMID: 36871085 DOI: 10.1007/s00705-023-05713-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2022] [Accepted: 01/04/2023] [Indexed: 03/06/2023]
Abstract
Bovine leukemia virus (BLV) is a member of the genus Deltaretrovirus within the family Retroviridae that infects bovine B cells, causing persistent lymphocytosis and enzootic bovine leukosis (EBL) in a small fraction of infected cattle. As changes in the transcriptome of infected cells are important for BLV disease progression, comprehensive analysis of gene expression in different disease states is required. In this study, we performed an RNA-seq analysis using samples from non-EBL cattle with and without BLV infection. Subsequently, a transcriptome analysis was conducted in combination with previously obtained RNA-seq data from EBL cattle. We found several differentially expressed genes (DEGs) between the three groups. After screening and confirmation of target DEGs using real-time reverse transcription polymerase chain reaction, we found that 12 target genes were significantly upregulated in EBL cattle compared to BLV-infected cattle without lymphoma. In addition, the expression levels of B4GALT6, ZBTB32, EPB4L1, RUNX1T1, HLTF, MKI67, and TOP2A were significantly and positively correlated with the proviral load in BLV-infected cattle. Overexpression experiments revealed that these changes were independent of BLV tax or BLV AS1-S expression in vitro. Our study provides additional information on host gene expression during BLV infection and EBL development, which may be helpful for understanding the complexity of transcriptome profiles during disease progression.
Collapse
|
2
|
Comprehensive Comparison of Novel Bovine Leukemia Virus (BLV) Integration Sites between B-Cell Lymphoma Lines BLSC-KU1 and BLSC-KU17 Using the Viral DNA Capture High-Throughput Sequencing Method. Viruses 2022; 14:v14050995. [PMID: 35632737 PMCID: PMC9143949 DOI: 10.3390/v14050995] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2022] [Revised: 04/28/2022] [Accepted: 05/06/2022] [Indexed: 02/01/2023] Open
Abstract
Bovine leukemia virus (BLV) infects cattle and integrates into host DNA, causing enzootic bovine leukosis (EBL), an aggressive B-cell lymphoma. Here, we developed a novel proviral DNA-capture sequencing (proviral DNA-capture-seq) method investigating BLV proviral integration in two B-cell lymphoma lines, BLSC-KU1 and BLSC-KU17, derived from BLV-infected cattle with EBL. We designed BLV-specific biotinylated probes to capture the provirus genome and enrich libraries for next-generation sequencing. Validation showed high specificity and efficient enrichment of target sequence reads as well as identification of three BLV proviral integration sites on BLV persistently infected FLK-BLV cells as a positive control. We successfully detected a single BLV proviral integration site on chromosome 19 of BLSC-KU1 and chromosome 9 of BLSC-KU17, which were confirmed by standard PCR and Sanger sequencing. Further, a defective provirus in BLSC-KU1 and complete BLV proviral sequence in BLSC-KU17 were confirmed using long PCR and sequencing. This is the first study to provide comprehensive information on BLV proviral structure and viral integration in BLSC-KU1 and BLSC-KU17. Moreover, the proposed method can facilitate understanding of the detailed mechanisms underlying BLV-induced leukemogenesis and may be used as an innovative tool to screen BLV-infected cattle at risk at an earlier stage than those that have already developed lymphoma.
Collapse
|
3
|
Afzal S, Fiaz K, Noor A, Sindhu AS, Hanif A, Bibi A, Asad M, Nawaz S, Zafar S, Ayub S, Hasnain SB, Shahid M. Interrelated Oncogenic Viruses and Breast Cancer. Front Mol Biosci 2022; 9:781111. [PMID: 35419411 PMCID: PMC8995849 DOI: 10.3389/fmolb.2022.781111] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2021] [Accepted: 03/15/2022] [Indexed: 12/23/2022] Open
Abstract
Breast Cancer is a multifactorial disease and recent evidence that viruses have a greater role in its aetiology and pathophysiology than previously hypothesized, has garnered a lot of attention in the past couple of years. After the role of Mouse Mammary Tumour Virus (MMTV) in the oncogenesis of breast cancer has been proved in mice, search for similar viruses found quite a plausible relation of Human Papilloma Virus (HPV), Epstein–Barr virus (EBV), and Bovine Leukaemia Virus (BLV) with breast cancer. However, despite practical efforts to provide some clarity in this issue, the evidence that viruses cause breast cancer still remains inconclusive. Therefore, this article aims to clarify some ambiguity and elucidate the correlation of breast cancer and those particular viruses which are found to bring about the development of tumorigenesis by a previous infection or by their own oncogenic ability to manipulate the molecular mechanisms and bypass the immune system of the human body. Although many studies have reported, both, the individual and co-existing presence of HPV, EBV, MMTV, and BLV in patient sample tissues, particularly in Western women, and proposed oncogenic mechanisms, majority of the collective survey of literature fails to provide a delineated and strong conclusive evidence that viruses do, in fact, cause breast cancer. Measures to prevent these viral infections may curb breast cancer cases, especially in the West. More studies are needed to provide a definite conclusion.
Collapse
|
4
|
Marawan MA, Alouffi A, El Tokhy S, Badawy S, Shirani I, Dawood A, Guo A, Almutairi MM, Alshammari FA, Selim A. Bovine Leukaemia Virus: Current Epidemiological Circumstance and Future Prospective. Viruses 2021; 13:v13112167. [PMID: 34834973 PMCID: PMC8618541 DOI: 10.3390/v13112167] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2021] [Revised: 10/23/2021] [Accepted: 10/24/2021] [Indexed: 11/23/2022] Open
Abstract
Bovine leukaemia virus (BLV) is a deltaretrovirus that is closely related to human T-cell leukaemia virus types 1 and 2 (HTLV-1 and -2). It causes enzootic bovine leukosis (EBL), which is the most important neoplastic disease in cattle. Most BLV-infected cattle are asymptomatic, which potentiates extremely high shedding rates of the virus in many cattle populations. Approximately 30% of them show persistent lymphocytosis that has various clinical outcomes; only a small proportion of animals (less than 5%) exhibit signs of EBL. BLV causes major economic losses in the cattle industry, especially in dairy farms. Direct costs are due to a decrease in animal productivity and in cow longevity; indirect costs are caused by restrictions that are placed on the import of animals and animal products from infected areas. Most European regions have implemented an efficient eradication programme, yet BLV prevalence remains high worldwide. Control of the disease is not feasible because there is no effective vaccine against it. Therefore, detection and early diagnosis of the disease are essential in order to diminish its spreading and the economic losses it causes. This review comprises an overview of bovine leukosis, which highlights the epidemiology of the disease, diagnostic tests that are used and effective control strategies.
Collapse
Affiliation(s)
- Marawan A. Marawan
- The State Key Laboratory of Agricultural Microbiology, Huazhong Agriculture University, Wuhan 430070, China; (I.S.); (A.D.)
- College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China
- Department of Animal Medicine (Infectious Diseases), Faculty of Veterinary Medicine, Benha University, Toukh 13736, Egypt;
- Correspondence: (M.A.M.); (A.G.); (A.S.)
| | - Abdulaziz Alouffi
- King Abdulaziz City for Science and Technology, Riyadh 12354, Saudi Arabia;
- The Chair of Vaccines Research for Infectious Diseases, King Saud University, Riyadh 11495, Saudi Arabia;
| | - Suleiman El Tokhy
- Department of Pharmaceutical Technology, Faculty of Pharmacy, Tanta University, Tanta 31111, Egypt;
| | - Sara Badawy
- Department of Pathology, Faculty of Veterinary Medicine, Benha University, Toukh 13736, Egypt;
- Natural Reference Laboratory of Veterinary Drug Residues (HZAU), MAO Key Laboratory for Detection of Veterinary Drug Residues Huazhong Agricultural University, Wuhan 430070, China
| | - Ihsanullah Shirani
- The State Key Laboratory of Agricultural Microbiology, Huazhong Agriculture University, Wuhan 430070, China; (I.S.); (A.D.)
- College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China
- Para-Clinic Department, Faculty of Veterinary Medicine, Jalalabad 2601, Afghanistan
| | - Ali Dawood
- The State Key Laboratory of Agricultural Microbiology, Huazhong Agriculture University, Wuhan 430070, China; (I.S.); (A.D.)
- College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China
- Infectious Diseases, Medicine Department, Faculty of Veterinary Medicine, University of Sadat City, Sadat City 32897, Egypt
| | - Aizhen Guo
- The State Key Laboratory of Agricultural Microbiology, Huazhong Agriculture University, Wuhan 430070, China; (I.S.); (A.D.)
- College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China
- Hubei International Scientific and Technological Cooperation Base of Veterinary Epidemiology, Huazhong Agricultural University, Wuhan 430070, China
- Correspondence: (M.A.M.); (A.G.); (A.S.)
| | - Mashal M. Almutairi
- The Chair of Vaccines Research for Infectious Diseases, King Saud University, Riyadh 11495, Saudi Arabia;
- Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 22334, Saudi Arabia
| | - Fahdah Ayed Alshammari
- College of Sciences and Literature Microbiology, Nothern Border University, Arar 73211, Saudi Arabia;
| | - Abdelfattah Selim
- Department of Animal Medicine (Infectious Diseases), Faculty of Veterinary Medicine, Benha University, Toukh 13736, Egypt;
- Correspondence: (M.A.M.); (A.G.); (A.S.)
| |
Collapse
|
5
|
Bai L, Borjigin L, Sato H, Takeshima SN, Asaji S, Ishizaki H, Kawashima K, Obuchi Y, Sunaga S, Ando A, Inoko H, Wada S, Aida Y. Kinetic Study of BLV Infectivity in BLV Susceptible and Resistant Cattle in Japan from 2017 to 2019. Pathogens 2021; 10:pathogens10101281. [PMID: 34684230 PMCID: PMC8537920 DOI: 10.3390/pathogens10101281] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2021] [Revised: 10/01/2021] [Accepted: 10/02/2021] [Indexed: 11/30/2022] Open
Abstract
Bovine leukemia virus (BLV) is the causative agent of enzootic bovine leukosis. Polymorphism in bovine lymphocyte antigen (BoLA)-DRB3 alleles is related to susceptibility to BLV proviral load (PVL), which is a useful index for estimating disease progression and transmission risk. However, whether differential BoLA-DRB3 affects BLV infectivity remains unknown. In a three-year follow-up investigation using a luminescence syncytium induction assay for evaluating BLV infectivity, we visualized and evaluated the kinetics of BLV infectivity in cattle with susceptible, resistant and neutral BoLA-DRB3 alleles which were selected from 179 cattle. Susceptible cattle showed stronger BLV infectivity than both resistant and neutral cattle. The order of intensity of BLV infectivity was as follows: susceptible cattle > neutral cattle > resistant cattle. BLV infectivity showed strong positive correlation with PVL at each testing point. BLV-infected susceptible cattle were found to be at higher risk of horizontal transmission, as they had strong infectivity and high PVL, whereas BLV-infected resistant cattle were low risk of BLV transmission owing to weak BLV infection and low PVL. Thus, this is the first study to demonstrate that the BoLA-DRB3 polymorphism is associated with BLV infection.
Collapse
Affiliation(s)
- Lanlan Bai
- Photonics Control Technology Team, RIKEN Center for Advanced Photonics, 2-1 Hirosawa, Wako 351-0198, Saitama, Japan; (L.B.); (S.-N.T.); (S.W.)
- Viral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako 351-0198, Saitama, Japan; (L.B.); (H.S.)
| | - Liushiqi Borjigin
- Viral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako 351-0198, Saitama, Japan; (L.B.); (H.S.)
| | - Hirotaka Sato
- Viral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako 351-0198, Saitama, Japan; (L.B.); (H.S.)
| | - Shin-Nosuke Takeshima
- Photonics Control Technology Team, RIKEN Center for Advanced Photonics, 2-1 Hirosawa, Wako 351-0198, Saitama, Japan; (L.B.); (S.-N.T.); (S.W.)
- Viral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako 351-0198, Saitama, Japan; (L.B.); (H.S.)
- Department of Food and Nutrition, Jumonji University, 2-1-28 Sugasawa, Niiza 352-8510, Saitama, Japan
| | - Sakurako Asaji
- GenoDive Pharma Inc., 4-14-1 Naka-cho, Atsugi 243-0018, Kanagawa, Japan; (S.A.); (A.A.); (H.I.)
| | - Hiroshi Ishizaki
- Grazing Animal Unit, Division of Grassland Farming, Institute of Livestock and Grassland Science, NARO, 768 Senbonmatsu, Nasushiobara 329-2793, Tochigi, Japan;
| | - Keiji Kawashima
- Tobu and General Agricultural Office Livestock Hygiene Division, Ota 373-0805, Gunma, Japan;
| | - Yuko Obuchi
- Department of Agriculture Dairy and Livestock Division, Maebashi 371-8570, Gunma, Japan; (Y.O.); (S.S.)
| | - Shinji Sunaga
- Department of Agriculture Dairy and Livestock Division, Maebashi 371-8570, Gunma, Japan; (Y.O.); (S.S.)
| | - Asako Ando
- GenoDive Pharma Inc., 4-14-1 Naka-cho, Atsugi 243-0018, Kanagawa, Japan; (S.A.); (A.A.); (H.I.)
- Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara 259-1119, Kanagasa, Japan
| | - Hidehito Inoko
- GenoDive Pharma Inc., 4-14-1 Naka-cho, Atsugi 243-0018, Kanagawa, Japan; (S.A.); (A.A.); (H.I.)
| | - Satoshi Wada
- Photonics Control Technology Team, RIKEN Center for Advanced Photonics, 2-1 Hirosawa, Wako 351-0198, Saitama, Japan; (L.B.); (S.-N.T.); (S.W.)
| | - Yoko Aida
- Viral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako 351-0198, Saitama, Japan; (L.B.); (H.S.)
- Department of Food and Nutrition, Jumonji University, 2-1-28 Sugasawa, Niiza 352-8510, Saitama, Japan
- Laboratory of Global Infectious Diseases Control Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan
- Correspondence: ; Tel.: +81-3-5841-5383
| |
Collapse
|
6
|
Lo CW, Takeshima SN, Okada K, Saitou E, Fujita T, Matsumoto Y, Wada S, Inoko H, Aida Y. Association of Bovine Leukemia Virus-Induced Lymphoma with BoLA-DRB3 Polymorphisms at DNA, Amino Acid, and Binding Pocket Property Levels. Pathogens 2021; 10:pathogens10040437. [PMID: 33917549 PMCID: PMC8067502 DOI: 10.3390/pathogens10040437] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2021] [Revised: 04/02/2021] [Accepted: 04/02/2021] [Indexed: 01/01/2023] Open
Abstract
Bovine leukemia virus (BLV) causes enzootic bovine leucosis, a malignant B-cell lymphoma in cattle. The DNA sequence polymorphisms of bovine leukocyte antigen (BoLA)-DRB3 have exhibited a correlation with BLV-induced lymphoma in Holstein cows. However, the association may vary between different cattle breeds. Furthermore, little is known about the relationship between BLV-induced lymphoma and DRB3 at the amino acid and structural diversity levels. Here, we comprehensively analyzed the correlation between BLV-induced lymphoma and DRB3 at DNA, amino acid, and binding pocket property levels, using 106 BLV-infected asymptomatic and 227 BLV-induced lymphoma Japanese black cattle samples. DRB3*011:01 was identified as a resistance allele, whereas DRB3*005:02 and DRB3*016:01 were susceptibility alleles. Amino acid association studies showed that positions 9, 11, 13, 26, 30, 47, 57, 70, 71, 74, 78, and 86 were associated with lymphoma susceptibility. Structure and electrostatic charge modeling further indicated that binding pocket 9 of resistance DRB3 was positively charged. In contrast, alleles susceptible to lymphoma were neutrally charged. Altogether, this is the first association study of BoLA-DRB3 polymorphisms with BLV-induced lymphoma in Japanese black cattle. In addition, our results further contribute to understanding the mechanisms regarding how BoLA-DRB3 polymorphisms mediate susceptibility to BLV-induced lymphoma.
Collapse
Affiliation(s)
- Chieh-Wen Lo
- Laboratory of Global Animal Resource Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan; (C.-W.L.); (Y.M.)
- Laboratory of Global Infectious Diseases Control Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan
| | - Shin-nosuke Takeshima
- Viral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan;
- Department of Food and Nutrition, Jumonji University, Niiza, Saitama 352-8510, Japan
| | - Kosuke Okada
- Iwate University, 7-360 Mukai-shinden Ukai, Takizawa, Iwate 020-0667, Japan;
| | - Etsuko Saitou
- Hyogo Prefectural Awaji Meat Inspection Center, 49-18 Shitoorinagata, Minamiawaji, Hyogo 656-0152, Japan;
| | - Tatsuo Fujita
- Livestock Research Institute of Oita Prefectural Agriculture, Forestry and Fisheries, Research Center, Kuju, Taketa, Oita 878-0201, Japan;
| | - Yasunobu Matsumoto
- Laboratory of Global Animal Resource Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan; (C.-W.L.); (Y.M.)
- Laboratory of Global Infectious Diseases Control Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan
| | - Satoshi Wada
- Photonics Control Technology Team, RIKEN Center for Advanced Photonics, Wako 351-0198, Japan;
| | - Hidetoshi Inoko
- Genome Analysis Division, GenoDive Pharma Inc., 4-14-1 Nakamachi, Atsugi-shi, Kanagawa 243-0018, Japan;
| | - Yoko Aida
- Laboratory of Global Animal Resource Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan; (C.-W.L.); (Y.M.)
- Laboratory of Global Infectious Diseases Control Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan
- Viral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan;
- Benno Laboratory, Baton Zone Program, RIKEN Cluster for Science, Technology and Innovation Hub, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
- Correspondence:
| |
Collapse
|